A Randomized, Phase III Trial to Evaluate Rucaparib Monotherapy as Maintenance Treatment in Patients With Newly Diagnosed Ovarian Cancer (ATHENA-MONO/GOG-3020/ENGOT-ov45).
- DOI
- 10.1200/jco.22.01003
- Published
- 2022 Dec 1
- Container
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1200/jco.22.01003,
title = {A Randomized, Phase III Trial to Evaluate Rucaparib Monotherapy as Maintenance Treatment in Patients With Newly Diagnosed Ovarian Cancer (ATHENA-MONO/GOG-3020/ENGOT-ov45).},
author = {Monk BJ and Parkinson C and Lim MC and O'Malley DM and Oaknin A and Wilson MK and Coleman RL and Lorusso D and Bessette P and Ghamande S and Christopoulou A and Provencher D and Prendergast E and Demirkiran F and Mikheeva O and Yeku O and Chudecka-Glaz A and Schenker M and Littell RD and Safra T and Chou HH and Morgan MA and Drochýtek V and Barlin JN and Van Gorp T and Ueland F and Lindahl G and Anderson C and Collins DC and Moore K and Marme F and Westin SN and McNeish IA and Shih D and Lin KK and Goble S and Hume S and Fujiwara K and Kristeleit RS},
year = {2022},
journal = {Journal of clinical oncology : official journal of the American Society of Clinical Oncology},
doi = {10.1200/jco.22.01003},
url = {https://doi.org/10.1200/jco.22.01003}
}RIS
TY - JOUR TI - A Randomized, Phase III Trial to Evaluate Rucaparib Monotherapy as Maintenance Treatment in Patients With Newly Diagnosed Ovarian Cancer (ATHENA-MONO/GOG-3020/ENGOT-ov45). AU - Monk BJ AU - Parkinson C AU - Lim MC AU - O'Malley DM AU - Oaknin A AU - Wilson MK AU - Coleman RL AU - Lorusso D AU - Bessette P AU - Ghamande S AU - Christopoulou A AU - Provencher D AU - Prendergast E AU - Demirkiran F AU - Mikheeva O AU - Yeku O AU - Chudecka-Glaz A AU - Schenker M AU - Littell RD AU - Safra T AU - Chou HH AU - Morgan MA AU - Drochýtek V AU - Barlin JN AU - Van Gorp T AU - Ueland F AU - Lindahl G AU - Anderson C AU - Collins DC AU - Moore K AU - Marme F AU - Westin SN AU - McNeish IA AU - Shih D AU - Lin KK AU - Goble S AU - Hume S AU - Fujiwara K AU - Kristeleit RS PY - 2022 JO - Journal of clinical oncology : official journal of the American Society of Clinical Oncology DO - 10.1200/jco.22.01003 UR - https://doi.org/10.1200/jco.22.01003 ER -
APA
BJ, M., C, P., MC, L., DM, O., A, O., MK, W., RL, C., D, L., P, B., S, G., A, C., D, P., E, P., F, D., O, M., O, Y., A, C., M, S., RD, L., T, S., HH, C., MA, M., V, D., JN, B., T, V. G., F, U., G, L., C, A., DC, C., K, M., F, M., SN, W., IA, M., D, S., KK, L., S, G., S, H., K, F., & RS, K. (2022). A Randomized, Phase III Trial to Evaluate Rucaparib Monotherapy as Maintenance Treatment in Patients With Newly Diagnosed Ovarian Cancer (ATHENA-MONO/GOG-3020/ENGOT-ov45).. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. https://doi.org/10.1200/jco.22.01003
Source records
- pubmed · retrieved 2026-09-26T01:17:56.420Z